Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
BLK
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
globenewswire.com
5 hours ago
benzinga.com
6 hours ago
reuters.com
16 hours ago
marketwatch.com
16 hours ago
benzinga.com
18 hours ago
zacks.com
19 hours ago
Earnings Growth
YoY
Current
Estimates
Q3.23
+14%
10.91
vs 9.55
Q4.23
+8%
9.66
vs 8.93
Q1.24
+24%
9.81
vs 7.93
Q2.24
+12%
10.36
vs 9.28
Q3.24
+5%
11.46
vs 10.91
Q4.24
+24%
11.93
vs 9.66
Q1.25
+15%
11.3
vs 9.81
Q2.25
+16%
12.05
vs 10.36
Q3.25
+3%
11.79
vs 11.46
Q4.25
+4%
12.4
vs 11.93
Sales Growth
YoY
Current
Estimates
Q3.23
+5%
4.5B vs 4.3B
Q4.23
+7%
4.6B vs 4.3B
Q1.24
+11%
4.7B vs 4.2B
Q2.24
+8%
4.8B vs 4.5B
Q3.24
+15%
5.2B vs 4.5B
Q4.24
+23%
5.7B vs 4.6B
Q1.25
+12%
5.3B vs 4.7B
Q2.25
+13%
5.4B vs 4.8B
Q3.25
+20%
6.2B vs 5.2B
Q4.25
+14%
6.5B vs 5.7B
Return on Equity
QoQ
Q1.23
+3%
0.03
vs 0.03
Q2.23
+4%
0.04
vs 0.03
Q3.23
+4%
0.04
vs 0.04
Q4.23
+3%
0.03
vs 0.04
Q1.24
+4%
0.04
vs 0.03
Q2.24
+4%
0.04
vs 0.04
Q3.24
+4%
0.04
vs 0.04
Q4.24
+4%
0.04
vs 0.04
Q1.25
+3%
0.03
vs 0.04
Q2.25
+3%
0.03
vs 0.03
Institutionnal Ownership
QoQ
Q1.23
1893
1.9K
vs 1.9K
0%
Q2.23
1903
1.9K
vs 1.9K
1%
Q3.23
1853
1.9K
vs 1.9K
-3%
Q4.23
1997
2K
vs 1.9K
8%
Q1.24
2029
2K
vs 2K
2%
Q2.24
2009
2K
vs 2K
-1%
Q3.24
1698
1.7K
vs 2K
-15%
Q4.24
2135
2.1K
vs 1.7K
26%
Q1.25
2187
2.2K
vs 2.1K
2%
Q2.25
2212
2.2K
vs 2.2K
1%
Forecast
2026-Revenue
2026-EPS
2026-EBITDA
Analyst rating
Price Target
1114.75(-1.50%)
Number of analyst
4
Last analyst upgrade/downgrade
Barclays
initialisePrevious: Not converted
2024-08-27
Now: Overweight
Cowen & Co.
upgradePrevious: Not converted
2024-01-16
Now: Outperform
Exane BNP Paribas
upgradePrevious: Not converted
2023-12-12
Now: Outperform
Keefe, Bruyette & Woods
upgradePrevious: Market Perform
2023-07-10
Now: Outperform
Quote Panel
Key Metrics
Relative Strength
BLK
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|